AOC is at it again. She is trying to take credit for a deal on an AIDS drug that was made four years ago. But to hear her tell it, she pulled this off single handedly. The drugmaker will allow a generic version to come out before their patent runs out.
First. AOC’s false statement:
“In my first 11 months I’ve cosponsored 339 pieces of legislation, authored 15, took on Big Pharma w/ my colleagues in hearings that brought PreP generic a year early & exposed abuse of power. In 4 years, you’ve jailed kids & made corruption the cause celebré. Try to keep up.”
So, in truth did AOC and her Democratic cronies really win the battle over PreP? No. Gilead, the manufacturer of PreP agreed in 2014 that they would allow a generic version of their drug to be released in 2020. AOC had absolutely nothing to do with it. She hasn’t even been in congress for a year, so how could she possibly take credit for something that occurred in 2014?
Next thing you know she will claim credit for the Bill of Rights and the 16th Amendment.
According to the Beacon’s report, Gilead — which is the pharmaceutical company behind PrEP, an HIV-prevention drug — agreed to allow a generic version of the drug to be released to the market in 2014.
The outlet reported that the pharmaceutical company’s patent for the active ingredient in Truvada, which is the company’s HIV prevention drug, will expire in 2021 and prohibits the majority of competitors from duplicating the medication. In 2014, however, Gilead and Teva Pharmaceutical reached a legal settlement that authorized Teva to sell the generic form of Truvada beginning in 2020.
Gilead representative Douglas Brooks issued remarks on the move in May, insisting that the legal settlement had nothing to do with the government, and insisted that lawmakers — including Ocasio-Cortez — had nothing to do with the agreement.